Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-19 to 2023-09-29
Current total value of award: $10571594
Description: NCE MODIFICATION AND DODAAC CHANGE PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022 TO SBIR PHASE III-COVID-ARDS CLINICAL TRIAL.